ReviewAnnals of neurology2017
The missing, the short, and the long: Levodopa responses and dopamine actions.
Abstract readReview
In one paragraph
Review in Annals of neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Long-Duration Response to Levodopa in Patients with Early Parkinson's Disease: Pharmacodynamics, Neuroplasticity, and Clinical Implications.Biomedicines · 2026Review
- Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment.Journal of Parkinson's disease · 2026Review
- The Dark Matter of Levodopa Pharmacodynamics.Movement disorders : official journal of the Movement Disorder Society · 2026Article
- Resting-state motor network connectivity as a biomarker of Levodopa response in Parkinson's disease.Brain imaging and behavior · 2026Review
- Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder.Brain : a journal of neurology · 2025Article
- Disease-Modifying Trials in Treated Parkinson's Disease: "Stable Treated" Does Not Equate with Biological Stability.Movement disorders : official journal of the Movement Disorder Society · 2025Review
- Striatal Dopamine Actions and Movement: Inferences from Parkinson Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025Review
- Neuroplasticity in Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2024Review
- Motivational Vigor in Parkinson's Disease Requires the Short and Long Duration Response to Levodopa.Movement disorders : official journal of the Movement Disorder Society · 2024Article
- Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2023Review
- Normalization effect of dopamine replacement therapy on brain functional connectome in Parkinson's disease.Human brain mapping · 2023Article
- Striatal Dopamine: The Cement of the Brain?: Jeong H, Taylor A, Floeder JR, et al. Mesolimbic dopamine release conveys causal associations. Science 2022;378:eabq6740.: Jeong H, Taylor A, Floeder JR, et al. Mesolimbic dopamine release conveys causal associations. Science 2022;378:eabq6740.Movement disorders : official journal of the Movement Disorder Society · 2023Article
- Electroanalytical Overview: The Determination of Levodopa (L-DOPA).ACS measurement science au · 2023Review
- Learning critically drives parkinsonian motor deficits through imbalanced striatal pathway recruitment.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Long-term levodopa ameliorates sequence effect in simple, but not complex walking in early Parkinson's disease patients.Parkinsonism & related disorders · 2023Article
- Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment.Clinical parkinsonism & related disorders · 2023Review
- Current Knowledge on the Background, Pathophysiology and Treatment of Levodopa-Induced Dyskinesia-Literature Review.Journal of clinical medicine · 2021Review
- Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson's Disease.Frontiers in cellular neuroscience · 2021Article
- Frequency-Specific Effects of Galvanic Vestibular Stimulation on Response-Time Performance in Parkinson's Disease.Frontiers in neurology · 2021Article
- Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease.Brain communications · 2021Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors.
Roger L AlbinDepartment of Neurology, University of Michigan; Neurology Service & Geriatrics Research, Education, and Clinical Center, VA Ann Arbor Healthcare System; and, University of Michigan Morris K. Udall Center of Excellence for Parkinson's Disease Research, Ann Arbor, MI.
Daniel K LeventhalDepartment of Neurology, University of Michigan; and Neurology Service & Geriatrics Research, Education, and Clinical Center, VA Ann Arbor Healthcare System, Ann Arbor, MI.
Funding
Public Outreach and Education CoreP50NS091856 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAUER, WILLIAM T. · 2014 to 2019
$10.1MNeuronal Oscillations and Dysregulated Motor Learning in Parkinsonian RatsK08NS072183 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEVENTHAL, DANIEL K · 2013 to 2017
$938kSerotonin and AmyloidopathyR56NS082941 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2014 to 2014
$680kCholinergic Interneurons in Tourette SyndromeR21NS088302 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2014 to 2015
$427kNINDS NIH HHS K08 NS072183NINDS NIH HHS P50 NS091856NINDS NIH HHS R21 NS088302NINDS NIH HHS R56 NS082941
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antiparkinson AgentsDopamineDopamine AgonistsHumansLevodopaParkinson DiseaseTimeAntiparkinson AgentsDopamineDopamine AgonistsLevodopa
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.